Computational characterization of Plasmodium falciparum proteomic data for screening of potential vaccine candidates

Human Immunology

Volumn 71, Issue 2, 2010, Pages 136-143

  Singh, Satarudra P ^a,b   Khan, Feroz ^c   Mishra, Bhartendu N ^b  

^a AMITY UNIVERSITY   (India)

^b INSTITUTE OF ENGINEERING AND TECHNOLOGY   (India)

^c CSIR CENTRAL INSTITUTE OF MEDICINAL AND AROMATIC PLANTS   (India)

Author keywords

Multiepitope; Plasmodium falciparum; Proteomics; Supertypes; Vaccine

Indexed keywords

ADHESIN; EPITOPE; HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA B ANTIGEN; HLA DR ANTIGEN; MALARIA VACCINE; SIGNAL PEPTIDE;

ANTIGEN BINDING; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; COMPUTER PREDICTION; CONTROLLED STUDY; DRUG SCREENING; IMMUNOGENICITY; MATHEMATICAL COMPUTING; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEOMICS;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, PROTOZOAN; EPITOPE MAPPING; EPITOPES, T-LYMPHOCYTE; HLA ANTIGENS; HUMANS; MALARIA VACCINES; MICE; MOLECULAR SEQUENCE DATA; PLASMODIUM FALCIPARUM; PROTEIN STRUCTURE, TERTIARY; PROTEOMICS;

EID: 74449083977     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2009.11.009     Document Type: Article

References (47)

1. Gardner M.J., Hall N., Fung E., White O., Berriman M., Hyman R.W., et al. Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 419 (2002) 498-511
2. Doolan D.L., Aguiar J.C., Weiss W.R., Sette A., Felgner P.L., Regis D.P., et al. Utilization of genomic sequence information to develop malaria vaccines. J Exp Biol 206 (2003) 3789-3802
3. Koganty R.R. Vaccine safety: A case for synthetic vaccine formulation. Expert Rev Vaccines 2 (2003) 725-727
4. Richie T.L., and Saul A. Progress and challenges for malaria vaccines. Nature 415 (2002) 694-701
5. Doolan D.L., Southwood S., Freilich D.A., Sidney J., Graber N.L., Shatney L., et al. Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data. Proc Natl Acad Sci USA 100 (2003) 9952-9957
6. Corradin G., Villard V., and Kajava A.V. Protein structure based strategies for antigen discovery and vaccine development against malaria and other pathogens. Endocr Metab Immune Disord Drug Targets 7 (2007) 259-265
7. Yuyang T., and Heng W. Construction and immunogenicity prediction of Plasmodium falciparum CTL epitope minigene vaccine. Sci China C Life Sci 44 (2000) 207-215
8. Prieur E., Gilbert S.C., Schneider J., Moore A.C., Sheu E.G., Goonetilleke N., et al. A Plasmodium falciparum candidate vaccine based on a six-antigen polyprotein encoded by recombinant poxviruses. Proc Natl Acad Sci USA 101 (2004) 290-295
9. Zhou Z., Todd C.W., Wohlhueter R.M., Price A., Xiao L., Schnake P., et al. Development, characterization and immunogenicity of a multi-stage, multi-valent Plasmodium falciparum vaccine antigen (FALVAC-1A) expressed in Escherichia coli. Hum Vaccin 2 (2006) 14-23
10. Calvo-Calle J.M., Oliveira G.A., Watta C.O., Soverow J., Parra-Lopez C., and Nardin E.H. A linear peptide containing minimal T- and B-cell epitopes of Plasmodium falciparum circumsporozoite protein elicits protection against transgenic sporozoite challenge. Infect Immun 74 (2006) 6929-6939
11. Ozarkar A.D., Prakash D., Deobagkar D.N., and Deobagkar D.D. Prediction of B cell and T cell epitopes of DBLalpha domain in Plasmodium falciparum malaria vaccine candidate var gene. Protein Pept Lett 14 (2007) 528-530
12. Plebanski M., and Hill A.V. The immunology of malaria infection. Curr Opin Immunol 12 (2000) 437-441
13. Buteau C., Markovic S.N., and Celis E. Challenges in the development of effective peptide vaccines for cancer. Mayo Clin Proc 77 (2002) 339-349
14. Singh S.P., Khan F., and Mishra B.N. Genomic predictions for T lymphocyte epitopes on Plasmodium falciparum (Malaria). Online J Bioinform 7 (2006) 69-73
15. Kobayashi H., Lu J., and Celis E. Identification of helper T cell epitopes that encompass or lie proximal to cytotoxic T cell epitopes in the gp100 melanoma tumor antigen. Cancer Res 61 (2001) 7577-7584
16. Doytchinova I.A., and Flower D.R. In silico identification of supertypes for class II MHCs. J Immunol 174 (2005) 7085-7095
17. Lund O., Nielsen M., Kesmir C., Petersen A.G., Lundegaard C., Worning P., et al. Definition of supertypes for HLA molecules using clustering of specificity matrices. Immunogenetics 55 (2004) 797-810
18. Reche P.A., and Reinherz E.L. Definition of MHC supertypes through clustering of MHC peptide-binding repertoires. Methods Mol Biol 409 (2007) 163-173
19. Sidney J., Peters B., Frahm N., Brander C., and Sette A. HLA class I supertypes: A revised and updated classification. BMC Immunol 9 (2008) 1
20. Florens L., Washburn M.P., Raine J.D., Anthony R.M., Grainger M., Haynes J.D., et al. A proteomic view of the Plasmodium falciparum life cycle. Nature 419 (2002) 520-526
21. Doytchinova I.A., and Flower D.R. VaxiJen: A server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinformatics 8 (2007) 4
22. Doytchinova I.A., and Flower D.R. Bioinformatics approach for identifying parasite and fungal candidate subunit vaccines. Open Vaccine J 1 (2008) 22-26
23. Ansari F.A., Kumar N., Bala Subramanyam M., Gnanamani M., and Ramachandran S. MAAP: Malarial adhesins and adhesin-like proteins predictor. Proteins 70 (2008) 659-666
24. Sachdeva G., Kumar K., Jain P., and Ramachandran S. SPAAN: A software program for prediction of adhesins and adhesin-like proteins using neural networks. Bioinformatics 21 (2005) 483-491
25. Emanuelsson O., Nielsen H., Brunak S., and von Heijne G. Predicting subcellular localization of proteins based on their N-terminal amino acid sequence. J Mol Biol 300 (2000) 1005-1016. http://dx.doi.org/10.1006/jmbi.2000.3903
26. Bendtsen J.D., Nielsen H., Heijne G., and Brunak S. Improved prediction of signal peptides: SignalP 3.0. J Mol Biol 340 (2004) 783-795
27. Krogh A., Larsson B., Heijne G., and Sonnhammer E.L. Predicting transmembrane protein topology with a hidden Markov model: Application to complete genomes. J Mol Biol 305 (2001) 567-580
28. Saha S., and Raghava G.P. Algpred: Prediction of allergenic proteins and mapping of IgE epitopes. Nucleic Acids Res 34 (2006) W202-W209
29. Altschul S.F., Gish W., Miller W., Myers E.W., and Lipman D.J. Basic local alignment search tool. J Mol Biol 215 (1990) 403-410
30. Chen F., Mackey A.J., Stoeckert Jr. C.J., and Roos D.S. Ortho MCL-DB: Querying a comprehensive multi-species collection of ortholog groups. Nucleic Acids Res 34 (2006) D363-D368
31. Larsen M.V., Lundegaard C., Lamberth K., Buus S., Lund O., and Nielsen M. Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction. BMC Bioinformatics 8 (2007) 424
32. Larsen M.V., Lundegaard C., Lamberth K., Buus S., Brunak S., Lund O., et al. An integrative approach to CTL epitope prediction: A combined algorithm integrating MHC-I binding, TAP transport efficiency, and proteasomal cleavage predictions. Eur J Immunol 35 (2005) 2295-2303
33. Zhang G.L., Khan A.M., Srinivasan K.N., August J.T., and Brusic V. MULTIPRED: A computational system for prediction of promiscuous HLA binding peptides. Nucleic Acids Res 33 (2005) W172-W179
34. Beaver J.E., Bourne P.E., and Ponomarenko J.V. EpitopeViewer: A Java application for the visualization and analysis of immune epitopes in the Immune Epitope Database and Analysis Resource (IEDB). Immunome Res 3 (2007) 3
35. Sette A., Newman M., Livingston B., McKinney D., Sidney J., Ishioka G., et al. Optimizing vaccine design for cellular processing, MHC binding and TCR recognition. Tissue Antigens 59 (2002) 443-451
36. Singh S.P., and Mishra B.N. Prediction of MHC binding peptide using Gibbs motif sampler, weight matrix and artificial neural network. Bioinformation 3 (2008) 150-155
37. Threlkeld S.C., Wentworth P.A., Kalams S.A., Wilkes B.M., Ruhl D.J., Keogh E., et al. Degenerate and promiscuous recognition by CTL of peptides presented by the MHC class I A3-like superfamily: Implications for vaccine development. J Immunol 159 (1997) 1648-1657
38. Bertoni R., Sidney J., Fowler P., Chesnut R.W., Chisari F.V., and Sette A. Human histocompatibility leukocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis. J Clin Invest 100 (1997) 503-513
39. Chang K.M., Gruener N.H., Southwood S., Sidney J., Pape G.R., Chisari F.V., et al. Identification of HLA-A3 and -B7-restricted CTL response to hepatitis C virus in patients with acute and chronic hepatitis C. J Immunol 162 (1999) 1156-1164
40. Doolan D.L., Southwood S., Chesnut R., Appella E., Gomez E., Richards A., et al. HLA-DR-promiscuous T cell epitopes from Plasmodium falciparum pre-erythrocytic-stage antigens restricted by multiple HLA class II alleles. J Immunol 165 (2000) 1123-1137
41. Sidney J., Southwood S., Mann D.L., Fernandez-Vina M.A., Newman M.J., and Sette A. Majority of peptides binding HLA-A*0201 with high affinity cross-react with other A2-supertype molecules. Hum Immunol 62 (2001) 1200-1216
42. Sette A., Vitiello A., Reherman B., Fowler P., Nayersina R., Kast W.M., et al. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J Immunol 153 (1994) 5586-5592
43. Southwood S., Sidney J., Kondo A., del Guercio M.F., Appella E., and Hoffman S. Several common HLA-DR types share largely overlapping peptide binding repertoires. J Immunol 160 (1998) 3363-3373
44. Hoffman S.L., Goh L.M., Luke T.C., Schneider I., Le T.P., Doolan D.L., et al. Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J Infect Dis 185 (2002) 1155-1164
45. Roestenberg M., McCall M., Hopman J., Wiersma J., Luty A.J.F., Gemert G.J.V., et al. Protection against a malaria challenge by sporozoite inoculation. N Engl J Med 361 (2009) 468-477
46. Sette A., Livingston B., McKinney D., Appella E., Fikes J., Sidney J., et al. The development of multi-epitope vaccines: Epitope identification, vaccine design and clinical evaluation. Biologicals 29 (2001) 271-276
47. Khan A.M., Miottob O., Heiny A.T., Salmond J., Srinivasan K.N., Nascimento E., et al. A systematic bioinformatics approach for selection of epitope based vaccine targets. Cell Immunol 244 (2006) 141-147